Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "007093-2025",
"tag": [
"award",
"contract"
],
"date": "2025-02-24T16:38:51Z",
"ocid": "ocds-h6vhtk-04e7a2",
"buyer": {
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000790498"
}
],
"awards": [
{
"id": "007093-2025-1",
"title": "Compounded Aseptic Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "007093-2025-2",
"title": "Compounded Aseptic Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-103751",
"name": "Qualasept Limited t/a Bath ASU"
}
],
"relatedLots": [
"2"
]
},
{
"id": "007093-2025-3",
"title": "Compounded Aseptic Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd"
}
],
"relatedLots": [
"3"
]
},
{
"id": "007093-2025-4",
"title": "Compounded Aseptic Medicines - All Other Presentations",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd"
},
{
"id": "GB-FTS-103751",
"name": "Qualasept Limited t/a Bath ASU"
},
{
"id": "GB-FTS-33758",
"name": "ITH Pharma Limited"
}
],
"relatedLots": [
"4"
]
}
],
"tender": {
"id": "NP38619",
"lots": [
{
"id": "1",
"title": "Compounded Aseptic Medicines",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nAtezolizumab\nCetuximab\nDoxorubicin\nEpirubicin\nInfliximab (Inflectra®), (Remicade®), (Remsima®)\nNivolumab\nPembrolizumab\nPertuzumab\nThe Authority intends to awarded all presentations within this Lot to a single supplier."
},
{
"id": "2",
"title": "Compounded Aseptic Medicines",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nCyclophosphamide\nFluorouracil\nIrinotecan\nMethotrexate\nRituximab (Mabthera®), (Rixathon®), (Truxima®)\nThe Authority intends to awarded all presentations within this Lot to a single supplier"
},
{
"id": "3",
"title": "Compounded Aseptic Medicines",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nBortezomib\nCarboplatin\nCisplatin\nDocetaxel\nGemcitabine\nOxaliplatin\nTrastuzumab (Herceptin®), (Herzuma®)\nVincristine\nThe Authority intends to awarded all presentations within this Lot to a single supplier."
},
{
"id": "4",
"title": "Compounded Aseptic Medicines - All Other Presentations",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nThe molecules included in this Lot are,\nBevacizumab\nCytarabine\nInfliximab (Zessly®)\nInsulin\nMethotrexate\nNatalizumab\nNivolumab\nPaclitaxel\nPemetrexed\nTocilizumab\nTrastuzumab (Kanjinti®), (Ontruzant®)\nTrastuzumab Subcutaneous\nVedolizumab\nEach product line will be treated as an individual Lot and awarded as an unranked multi-supplier framework."
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "Compounded Aseptic Medicines",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"techniques": {
"hasFrameworkAgreement": true
},
"description": "This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags\nto NHS Scotland.",
"reviewDetails": "The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication\nmethod used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority\nproposes to conclude the relevant framework agreement.\nThe bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering\ninto the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings\nto an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include\nthe setting aside of the decision to award the framework agreement to the winning tenderer.\nThe bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework\nagreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be\nestablished. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited\nto the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"procurementMethod": "limited",
"mainProcurementCategory": "goods",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector\nduring the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with\nRegulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015",
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"description": "The procurement falls outside the scope of application of the directive"
}
]
},
"parties": [
{
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"roles": [
"buyer"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "1 South Gyle Crescent"
},
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"contactPoint": {
"email": "claire.matheson3@nhs.scot",
"telephone": "+44 1312756000"
}
},
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Newbury, Berkshire",
"postalCode": "RG20 7QW",
"countryName": "United Kingdom",
"streetAddress": "Wallingford Road, Compton,"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Baxter Healthcare Ltd"
},
"contactPoint": {
"telephone": "+44 1635206000"
}
},
{
"id": "GB-FTS-103751",
"name": "Qualasept Limited t/a Bath ASU",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Corsham",
"postalCode": "SN13 9RG",
"countryName": "United Kingdom",
"streetAddress": "Unit A15 Fiveways Light Industrial Estate, Westwells Road,"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Qualasept Limited t/a Bath ASU"
}
},
{
"id": "GB-FTS-33758",
"name": "ITH Pharma Limited",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "London",
"postalCode": "NW10 7NZ",
"countryName": "United Kingdom",
"streetAddress": "Unit 4 Premier Park, Premier Park Road"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "ITH Pharma Limited"
},
"contactPoint": {
"faxNumber": "+44 2088388261",
"telephone": "+44 2088388260"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
}
}
],
"language": "en",
"contracts": [
{
"id": "007093-2025-1",
"title": "Compounded Aseptic Medicines",
"value": {
"amount": 13653346,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-1",
"dateSigned": "2025-02-24T00:00:00Z"
},
{
"id": "007093-2025-2",
"title": "Compounded Aseptic Medicines",
"value": {
"amount": 1565729,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-2",
"dateSigned": "2025-02-24T00:00:00Z"
},
{
"id": "007093-2025-3",
"title": "Compounded Aseptic Medicines",
"value": {
"amount": 1064777,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-3",
"dateSigned": "2025-02-24T00:00:00Z"
},
{
"id": "007093-2025-4",
"title": "Compounded Aseptic Medicines - All Other Presentations",
"value": {
"amount": 5085024,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-4",
"dateSigned": "2025-02-24T00:00:00Z"
}
],
"description": "The estimated value(s) of the Framework Agreement referred to in Section V.2.4 (comprising three (4) Lots) cover(s) the twelve (12)\nmonth duration of the proposed modification period of the Framework Agreement.\nNOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=790498.\n(SC Ref:790498)",
"initiationType": "tender"
}Complete JSON history (1 releases)
24 Feb 2025 · 007093-2025 · award, contract
{
"id": "007093-2025",
"tag": [
"award",
"contract"
],
"date": "2025-02-24T16:38:51Z",
"ocid": "ocds-h6vhtk-04e7a2",
"buyer": {
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"links": [
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000790498"
}
],
"awards": [
{
"id": "007093-2025-1",
"title": "Compounded Aseptic Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd"
}
],
"relatedLots": [
"1"
]
},
{
"id": "007093-2025-2",
"title": "Compounded Aseptic Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-103751",
"name": "Qualasept Limited t/a Bath ASU"
}
],
"relatedLots": [
"2"
]
},
{
"id": "007093-2025-3",
"title": "Compounded Aseptic Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd"
}
],
"relatedLots": [
"3"
]
},
{
"id": "007093-2025-4",
"title": "Compounded Aseptic Medicines - All Other Presentations",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd"
},
{
"id": "GB-FTS-103751",
"name": "Qualasept Limited t/a Bath ASU"
},
{
"id": "GB-FTS-33758",
"name": "ITH Pharma Limited"
}
],
"relatedLots": [
"4"
]
}
],
"tender": {
"id": "NP38619",
"lots": [
{
"id": "1",
"title": "Compounded Aseptic Medicines",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nAtezolizumab\nCetuximab\nDoxorubicin\nEpirubicin\nInfliximab (Inflectra®), (Remicade®), (Remsima®)\nNivolumab\nPembrolizumab\nPertuzumab\nThe Authority intends to awarded all presentations within this Lot to a single supplier."
},
{
"id": "2",
"title": "Compounded Aseptic Medicines",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nCyclophosphamide\nFluorouracil\nIrinotecan\nMethotrexate\nRituximab (Mabthera®), (Rixathon®), (Truxima®)\nThe Authority intends to awarded all presentations within this Lot to a single supplier"
},
{
"id": "3",
"title": "Compounded Aseptic Medicines",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nBortezomib\nCarboplatin\nCisplatin\nDocetaxel\nGemcitabine\nOxaliplatin\nTrastuzumab (Herceptin®), (Herzuma®)\nVincristine\nThe Authority intends to awarded all presentations within this Lot to a single supplier."
},
{
"id": "4",
"title": "Compounded Aseptic Medicines - All Other Presentations",
"hasOptions": false,
"description": "Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses,\nThe molecules included in this Lot are,\nBevacizumab\nCytarabine\nInfliximab (Zessly®)\nInsulin\nMethotrexate\nNatalizumab\nNivolumab\nPaclitaxel\nPemetrexed\nTocilizumab\nTrastuzumab (Kanjinti®), (Ontruzant®)\nTrastuzumab Subcutaneous\nVedolizumab\nEach product line will be treated as an individual Lot and awarded as an unranked multi-supplier framework."
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "2",
"relatedLot": "2",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "3",
"relatedLot": "3",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
},
{
"id": "4",
"relatedLot": "4",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto New Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "Compounded Aseptic Medicines",
"status": "complete",
"coveredBy": [
"GPA"
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"techniques": {
"hasFrameworkAgreement": true
},
"description": "This Framework Agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags\nto NHS Scotland.",
"reviewDetails": "The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication\nmethod used is not electronic) between the date on which the Authority despatches the VEAT notice and the date on which the Authority\nproposes to conclude the relevant framework agreement.\nThe bringing of court proceedings against the authority during the standstill period will automatically continue the prohibition on entering\ninto the framework agreement until the court proceedings are determined, discontinued or disposed of, or the court, by interim order, brings\nto an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include\nthe setting aside of the decision to award the framework agreement to the winning tenderer.\nThe bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework\nagreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be\nestablished. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited\nto the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"procurementMethod": "limited",
"mainProcurementCategory": "goods",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "This VEAT notice is to advise the need for modification to meet the additional demands of the Scottish Health and Social Care sector\nduring the current Covid-19 pandemic and to maintain necessary supply due to circumstances unforeseen by the Authority in line with\nRegulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015",
"procurementMethodRationaleClassifications": [
{
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"description": "The procurement falls outside the scope of application of the directive"
}
]
},
"parties": [
{
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"roles": [
"buyer"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "1 South Gyle Crescent"
},
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE",
"description": "Body governed by public law"
},
{
"id": "07",
"scheme": "COFOG",
"description": "Health"
}
]
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"contactPoint": {
"email": "claire.matheson3@nhs.scot",
"telephone": "+44 1312756000"
}
},
{
"id": "GB-FTS-4552",
"name": "Baxter Healthcare Ltd",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Newbury, Berkshire",
"postalCode": "RG20 7QW",
"countryName": "United Kingdom",
"streetAddress": "Wallingford Road, Compton,"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Baxter Healthcare Ltd"
},
"contactPoint": {
"telephone": "+44 1635206000"
}
},
{
"id": "GB-FTS-103751",
"name": "Qualasept Limited t/a Bath ASU",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Corsham",
"postalCode": "SN13 9RG",
"countryName": "United Kingdom",
"streetAddress": "Unit A15 Fiveways Light Industrial Estate, Westwells Road,"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Qualasept Limited t/a Bath ASU"
}
},
{
"id": "GB-FTS-33758",
"name": "ITH Pharma Limited",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "London",
"postalCode": "NW10 7NZ",
"countryName": "United Kingdom",
"streetAddress": "Unit 4 Premier Park, Premier Park Road"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "ITH Pharma Limited"
},
"contactPoint": {
"faxNumber": "+44 2088388261",
"telephone": "+44 2088388260"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
}
}
],
"language": "en",
"contracts": [
{
"id": "007093-2025-1",
"title": "Compounded Aseptic Medicines",
"value": {
"amount": 13653346,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-1",
"dateSigned": "2025-02-24T00:00:00Z"
},
{
"id": "007093-2025-2",
"title": "Compounded Aseptic Medicines",
"value": {
"amount": 1565729,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-2",
"dateSigned": "2025-02-24T00:00:00Z"
},
{
"id": "007093-2025-3",
"title": "Compounded Aseptic Medicines",
"value": {
"amount": 1064777,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-3",
"dateSigned": "2025-02-24T00:00:00Z"
},
{
"id": "007093-2025-4",
"title": "Compounded Aseptic Medicines - All Other Presentations",
"value": {
"amount": 5085024,
"currency": "GBP"
},
"status": "active",
"awardID": "007093-2025-4",
"dateSigned": "2025-02-24T00:00:00Z"
}
],
"description": "The estimated value(s) of the Framework Agreement referred to in Section V.2.4 (comprising three (4) Lots) cover(s) the twelve (12)\nmonth duration of the proposed modification period of the Framework Agreement.\nNOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at https://www.publiccontractsscotland.gov.uk/Search/Search_Switch.aspx?ID=790498.\n(SC Ref:790498)",
"initiationType": "tender"
}